{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:46:42Z","timestamp":1793969202347,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shenzhen City's Key Medical Discipline-Department of Traditional Chinese Medicine Brain Disorders","award":["SZXK202302"],"award-info":[{"award-number":["SZXK202302"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471010"],"award-info":[{"award-number":["32471010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key-Area Research and Development Program of Guangdong Province","award":["2023B0303040004"],"award-info":[{"award-number":["2023B0303040004"]}]},{"name":"Shenzhen Key Laboratory of Neuroimmunomodulation for Neurological Diseases","award":["ZDSYS20220304163558001"],"award-info":[{"award-number":["ZDSYS20220304163558001"]}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20220818100802005"],"award-info":[{"award-number":["JCYJ20220818100802005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Significant data suggest that cerebral accumulation of the amyloid \u03b2-protein (A\u03b2) plays an initiating role in Alzheimer\u2019s disease (AD), however, A\u03b2 can exist in multiple different forms and it is not clear which of these contribute to the propagation of amyloid or toxicity. When injected into animal models, A\u03b2-containing homogenates from AD or APP transgenic mouse brain accelerate amyloid pathology, but the nature of the seeding species remain ill-defined. In this study, we took advantage of well-characterized brain extracts from human AD cases and\n                    <jats:italic>App<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>NL\u2212F\/NL\u2212F<\/jats:italic>\n                    <\/jats:sup>\n                    mice, to assess the seeding activity of diffusible forms of A\u03b2. Extracts containing readily diffusible forms of A\u03b2, (which we refer to as\n                    <jats:italic>S extracts<\/jats:italic>\n                    ) are obtained by soaking tissue slices in physiological buffer and removing large non-diffusing material by centrifugation. Such AD brain\n                    <jats:italic>S extracts<\/jats:italic>\n                    are potent neuritotoxins and contain a broad range of different sized forms A\u03b2. When tested at approximately ten months after a single intracerebral injection of AD brain\n                    <jats:italic>S extract<\/jats:italic>\n                    ,\n                    <jats:italic>App<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>NL\u2212F\/NL\u2212F<\/jats:italic>\n                    <\/jats:sup>\n                    mice exhibited a significant perturbation of learned behavior, together with accelerated cerebral amyloid deposition, microgliosis, astrocytosis, neuronal dystrophy and synaptic loss. Importantly, inoculation of\n                    <jats:italic>App<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>NL\u2212F\/NL\u2212F<\/jats:italic>\n                    <\/jats:sup>\n                    mice with\n                    <jats:italic>S extract<\/jats:italic>\n                    from a human control brain altered neither the memory of learned behavior nor the appearance of amyloid and associated pathologies. These results indicate that diffusible forms of A\u03b2 derived from AD brain can readily induce aggregation of endogenous A\u03b2 and accelerate negative outcomes associated with A\u03b2 accumulation.\n                  <\/jats:p>","DOI":"10.1186\/s40478-025-02032-w","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T21:20:16Z","timestamp":1748035216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Experimental evidence that readily diffusible forms of A\u03b2 from Alzheimer\u2019s disease brain have seeding activity"],"prefix":"10.1186","volume":"13","author":[{"given":"Simin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sasaguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi C.","family":"Saido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic M.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"10","key":"2032_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","volume":"21","author":"M Jucker","year":"2018","unstructured":"Jucker M, Walker LC (2018) Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat Neurosci 21(10):1341\u20131349","journal-title":"Nat Neurosci"},{"issue":"1","key":"2032_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13195-024-01487-8","volume":"16","author":"J Raine","year":"2024","unstructured":"Raine J et al (2024) Evaluating the inter-species transmission risk of amyloid beta peptide aggregates via ingestion. Alzheimers Res Ther 16(1):123","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2032_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","volume":"23","author":"GB Frisoni","year":"2022","unstructured":"Frisoni GB et al (2022) The probabilistic model of alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci 23(1):53\u201366","journal-title":"Nat Rev Neurosci"},{"key":"2032_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.conb.2020.02.003","volume":"61","author":"DM Walsh","year":"2020","unstructured":"Walsh DM, Selkoe DJ (2020) Amyloid beta-protein and beyond: the path forward in Alzheimer\u2019s disease. Curr Opin Neurobiol 61:116\u2013124","journal-title":"Curr Opin Neurobiol"},{"key":"2032_CR5","doi-asserted-by":"crossref","unstructured":"Beckman D et al (2019) Oligomeric Abeta in the monkey brain impacts synaptic integrity and induces accelerated cortical aging. Proc Natl Acad Sci U S A","DOI":"10.1073\/pnas.1902301116"},{"issue":"1","key":"2032_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40478-021-01266-8","volume":"9","author":"S Lam","year":"2021","unstructured":"Lam S et al (2021) Transmission of amyloid-beta and Tau pathologies is associated with cognitive impairments in a primate. Acta Neuropathol Commun 9(1):165","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2032_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s40478-020-01081-7","volume":"8","author":"AS Herard","year":"2020","unstructured":"Herard AS et al (2020) Induction of amyloid-beta deposits from serially transmitted, histologically silent, Abeta seeds issued from human brains. Acta Neuropathol Commun 8(1):205","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"2032_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00401-021-02345-9","volume":"142","author":"TT Roos","year":"2021","unstructured":"Roos TT et al (2021) Neuronal spreading and plaque induction of intracellular Abeta and its disruption of Abeta homeostasis. Acta Neuropathol 142(4):669\u2013687","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2032_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40478-022-01417-5","volume":"10","author":"E Baerends","year":"2022","unstructured":"Baerends E et al (2022) Modeling the early stages of Alzheimer\u2019s disease by administering intracerebroventricular injections of human native Abeta oligomers to rats. Acta Neuropathol Commun 10(1):113","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"2032_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41591-023-02729-2","volume":"30","author":"G Banerjee","year":"2024","unstructured":"Banerjee G et al (2024) Iatrogenic Alzheimer\u2019s disease in recipients of cadaveric pituitary-derived growth hormone. Nat Med 30(2):394\u2013402","journal-title":"Nat Med"},{"issue":"7736","key":"2032_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-018-0790-y","volume":"564","author":"SA Purro","year":"2018","unstructured":"Purro SA et al (2018) Transmission of amyloid-beta protein pathology from cadaveric pituitary growth hormone. Nature 564(7736):415\u2013419","journal-title":"Nature"},{"issue":"12","key":"2032_CR12","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41593-020-00737-w","volume":"23","author":"RE Uhlmann","year":"2020","unstructured":"Uhlmann RE et al (2020) Acute targeting of pre-amyloid seeds in Transgenic mice reduces Alzheimer-like pathology later in life. Nat Neurosci 23(12):1580\u20131588","journal-title":"Nat Neurosci"},{"issue":"10","key":"2032_CR13","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1038\/s41380-022-01686-5","volume":"27","author":"S Ziegler-Waldkirch","year":"2022","unstructured":"Ziegler-Waldkirch S et al (2022) Seed-induced Abeta deposition alters neuronal function and impairs olfaction in a mouse model of Alzheimer\u2019s disease. Mol Psychiatry 27(10):4274\u20134284","journal-title":"Mol Psychiatry"},{"issue":"1","key":"2032_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-022-01410-y","volume":"10","author":"S Lam","year":"2022","unstructured":"Lam S et al (2022) Pathological changes induced by Alzheimer\u2019s brain inoculation in amyloid-beta plaque-bearing mice. Acta Neuropathol Commun 10(1):112","journal-title":"Acta Neuropathol Commun"},{"key":"2032_CR15","doi-asserted-by":"crossref","unstructured":"Morales R et al (2021) Transmission of cerebral amyloid pathology by peripheral administration of misfolded Abeta aggregates. Mol Psychiatry","DOI":"10.1038\/s41380-021-01150-w"},{"issue":"9","key":"2032_CR16","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.15252\/embr.201744067","volume":"18","author":"L Ye","year":"2017","unstructured":"Ye L et al (2017) Abeta seeding potency peaks in the early stages of cerebral beta-amyloidosis. EMBO Rep 18(9):1536\u20131544","journal-title":"EMBO Rep"},{"issue":"1","key":"2032_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40478-018-0529-x","volume":"6","author":"A Ruiz-Riquelme","year":"2018","unstructured":"Ruiz-Riquelme A et al (2018) Prion-like propagation of beta-amyloid aggregates in the absence of APP overexpression. Acta Neuropathol Commun 6(1):26","journal-title":"Acta Neuropathol Commun"},{"key":"2032_CR18","doi-asserted-by":"publisher","first-page":"1108715","DOI":"10.3389\/fnins.2023.1108715","volume":"17","author":"W Hong","year":"2023","unstructured":"Hong W et al (2023) Methods for the isolation and analysis of Abeta from postmortem brain. Front Neurosci 17:1108715","journal-title":"Front Neurosci"},{"issue":"1","key":"2032_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","volume":"136","author":"W Hong","year":"2018","unstructured":"Hong W et al (2018) Diffusible, highly bioactive oligomers represent a critical minority of soluble Abeta in Alzheimer\u2019s disease brain. Acta Neuropathol 136(1):19\u201340","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2032_CR20","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/brain\/awz066","volume":"142","author":"G Brinkmalm","year":"2019","unstructured":"Brinkmalm G et al (2019) Identification of neurotoxic cross-linked amyloid-beta dimers in the Alzheimer\u2019s brain. Brain 142(5):1441\u20131457","journal-title":"Brain"},{"issue":"8","key":"2032_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14(8):837\u2013842","journal-title":"Nat Med"},{"issue":"49","key":"2032_CR22","doi-asserted-by":"publisher","first-page":"11947","DOI":"10.1523\/JNEUROSCI.2009-17.2017","volume":"37","author":"Z Wang","year":"2017","unstructured":"Wang Z et al (2017) Human Brain-Derived Abeta oligomers bind to synapses and disrupt synaptic activity in a manner that requires APP. J Neurosci 37(49):11947\u201311966","journal-title":"J Neurosci"},{"issue":"6453","key":"2032_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott B et al (2019) A vicious cycle of beta amyloid-dependent neuronal hyperactivation. Science 365(6453):559\u2013565","journal-title":"Science"},{"issue":"5","key":"2032_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T et al (2014) Single app knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci 17(5):661\u2013663","journal-title":"Nat Neurosci"},{"issue":"11","key":"2032_CR25","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jalz.2015.01.005","volume":"11","author":"JM Mc Donald","year":"2015","unstructured":"Mc Donald JM et al (2015) The aqueous phase of Alzheimer\u2019s disease brain contains assemblies built from approximately 4 and approximately 7\u00a0kda Abeta species. Alzheimers Dement 11(11):1286\u20131305","journal-title":"Alzheimers Dement"},{"issue":"5","key":"2032_CR26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y et al (2013) Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78(5):785\u2013798","journal-title":"Neuron"},{"issue":"7284","key":"2032_CR27","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen T et al (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463(7284):1035\u20131041","journal-title":"Nature"},{"issue":"3","key":"2032_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.stem.2008.08.003","volume":"3","author":"N Maherali","year":"2008","unstructured":"Maherali N et al (2008) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3(3):340\u2013345","journal-title":"Cell Stem Cell"},{"key":"2032_CR29","doi-asserted-by":"crossref","unstructured":"Li S et al (2025) Systematic evaluation of extracellular coating matrix on the differentiation of human induced pluripotent stem cells to cortical neurons. Int J Mol Sci, 26(1)","DOI":"10.3390\/ijms26010230"},{"issue":"1","key":"2032_CR30","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1038\/s41467-018-05068-w","volume":"9","author":"M Jin","year":"2018","unstructured":"Jin M et al (2018) An in vitro paradigm to assess potential anti-Abeta antibodies for Alzheimer\u2019s disease. Nat Commun 9(1):2676","journal-title":"Nat Commun"},{"key":"2032_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z (2019) The Y-Maze for assessment of Spatial working and reference memory in mice. Methods Mol Biol 1916:105\u2013111","journal-title":"Methods Mol Biol"},{"key":"2032_CR32","doi-asserted-by":"crossref","unstructured":"Pitts MW (2018) Barnes maze procedure for Spatial learning and memory in mice. Bio Protoc, 8(5)","DOI":"10.21769\/BioProtoc.2744"},{"issue":"6","key":"2032_CR33","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/alz.12457","volume":"18","author":"L Liu","year":"2022","unstructured":"Liu L et al (2022) An ultra-sensitive immunoassay detects and quantifies soluble Abeta oligomers in human plasma. Alzheimers Dement 18(6):1186\u20131202","journal-title":"Alzheimers Dement"},{"key":"2032_CR34","doi-asserted-by":"crossref","unstructured":"Stern AM et al (2023) Abundant Abeta fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer\u2019s disease brains. Neuron","DOI":"10.1101\/2022.10.18.512754"},{"issue":"1","key":"2032_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40478-023-01511-2","volume":"11","author":"Z Wang","year":"2023","unstructured":"Wang Z et al (2023) Learnings about Abeta from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer\u2019s disease immunotherapeutics. Acta Neuropathol Commun 11(1):39","journal-title":"Acta Neuropathol Commun"},{"key":"2032_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nlm.2016.07.001","volume":"135","author":"A Masuda","year":"2016","unstructured":"Masuda A et al (2016) Cognitive deficits in single app knock-in mouse models. Neurobiol Learn Mem 135:73\u201382","journal-title":"Neurobiol Learn Mem"},{"issue":"17","key":"2032_CR37","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H et al (2017) APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J 36(17):2473\u20132487","journal-title":"EMBO J"},{"issue":"2","key":"2032_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/ana.410330209","volume":"33","author":"SW Scheff","year":"1993","unstructured":"Scheff SW, Price DA (1993) Synapse loss in the Temporal lobe in Alzheimer\u2019s disease. Ann Neurol 33(2):190\u2013199","journal-title":"Ann Neurol"},{"issue":"1","key":"2032_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0197-4580(90)90059-9","volume":"11","author":"SW Scheff","year":"1990","unstructured":"Scheff SW, DeKosky ST, Price DA (1990) Quantitative assessment of cortical synaptic density in Alzheimer\u2019s disease. Neurobiol Aging 11(1):29\u201337","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2032_CR40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran E, De Strooper B (2022) The amyloid hypothesis in alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov 21(4):306\u2013318","journal-title":"Nat Rev Drug Discov"},{"key":"2032_CR41","doi-asserted-by":"crossref","unstructured":"Yue F et al (2021) Synthetic amyloid-beta oligomers drive early pathological progression of Alzheimer\u2019s disease in nonhuman primates. Iscience, 24(9)","DOI":"10.1016\/j.isci.2021.103207"},{"issue":"27","key":"2032_CR42","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.1073\/pnas.1206555109","volume":"109","author":"J Stohr","year":"2012","unstructured":"Stohr J et al (2012) Purified and synthetic Alzheimer\u2019s amyloid beta (Abeta) prions. Proc Natl Acad Sci U S A 109(27):11025\u201311030","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2032_CR43","doi-asserted-by":"crossref","unstructured":"He Z et al (2025) Amyloid-beta oligomers drive amyloid deposit and cascaded tau pathology of Alzheimer\u2019s disease in aged brains of non-human primates. J Genet Genomics","DOI":"10.1016\/j.jgg.2025.02.007"},{"issue":"9","key":"2032_CR44","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00702-005-0385-2","volume":"113","author":"RM Ridley","year":"2006","unstructured":"Ridley RM et al (2006) Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm (Vienna) 113(9):1243\u20131251","journal-title":"J Neural Transm (Vienna)"},{"issue":"28","key":"2032_CR45","doi-asserted-by":"publisher","first-page":"10329","DOI":"10.1073\/pnas.1408968111","volume":"111","author":"J Stohr","year":"2014","unstructured":"Stohr J et al (2014) Distinct synthetic Abeta prion strains producing different amyloid deposits in bigenic mice. Proc Natl Acad Sci U S A 111(28):10329\u201310334","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2032_CR46","doi-asserted-by":"crossref","unstructured":"Purro SA et al (2024) Induction and characterisation of A\u03b2 and Tau pathology in AppNL-F\/NL-F mice following inoculation with Alzheimer\u2019s disease brain homogenate. BioRxiv preprint","DOI":"10.1101\/2024.07.11.602448"},{"key":"2032_CR47","doi-asserted-by":"publisher","first-page":"807473","DOI":"10.3389\/fnins.2022.807473","volume":"16","author":"H Sasaguri","year":"2022","unstructured":"Sasaguri H et al (2022) Recent advances in the modeling of Alzheimer\u2019s disease. Front Neurosci 16:807473","journal-title":"Front Neurosci"},{"issue":"5","key":"2032_CR48","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/alz.12245","volume":"17","author":"G Salvado","year":"2021","unstructured":"Salvado G et al (2021) Cerebral amyloid-beta load is associated with neurodegeneration and gliosis: mediation by p-tau and interactions with risk factors early in the Alzheimer\u2019s continuum. Alzheimers Dement 17(5):788\u2013800","journal-title":"Alzheimers Dement"},{"key":"2032_CR49","doi-asserted-by":"crossref","unstructured":"Robert A, Scholl M, Vogels T (2021) Tau seeding mouse models with patient Brain-Derived aggregates. Int J Mol Sci, 22(11)","DOI":"10.3390\/ijms22116132"},{"issue":"34","key":"2032_CR50","doi-asserted-by":"publisher","first-page":"12754","DOI":"10.1074\/jbc.RA119.009487","volume":"294","author":"T Saito","year":"2019","unstructured":"Saito T et al (2019) Humanization of the entire murine Mapt gene provides a murine model of pathological human Tau propagation. J Biol Chem 294(34):12754\u201312765","journal-title":"J Biol Chem"},{"issue":"1","key":"2032_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-019-0725-3","volume":"7","author":"Z Skachokova","year":"2019","unstructured":"Skachokova Z et al (2019) Cerebrospinal fluid from Alzheimer\u2019s disease patients promotes Tau aggregation in Transgenic mice. Acta Neuropathol Commun 7(1):72","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"2032_CR52","doi-asserted-by":"publisher","first-page":"886","DOI":"10.2174\/1567205012666150710115022","volume":"12","author":"Z Skachokova","year":"2015","unstructured":"Skachokova Z et al (2015) Amyloid-beta in the cerebrospinal fluid of APP Transgenic mice does not show Prion-like properties. Curr Alzheimer Res 12(9):886\u2013891","journal-title":"Curr Alzheimer Res"},{"issue":"Pt 11","key":"2032_CR53","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/brain\/awu255","volume":"137","author":"SK Fritschi","year":"2014","unstructured":"Fritschi SK et al (2014) Highly potent soluble amyloid-beta seeds in human alzheimer brain but not cerebrospinal fluid. Brain 137(Pt 11):2909\u20132915","journal-title":"Brain"},{"issue":"6393","key":"2032_CR54","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/359325a0","volume":"359","author":"P Seubert","year":"1992","unstructured":"Seubert P et al (1992) Isolation and quantification of soluble Alzheimer\u2019s beta-peptide from biological fluids. Nature 359(6393):325\u2013327","journal-title":"Nature"},{"issue":"4","key":"2032_CR55","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1073\/pnas.94.4.1550","volume":"94","author":"K Johnson-Wood","year":"1997","unstructured":"Johnson-Wood K et al (1997) Amyloid precursor protein processing and A beta42 deposition in a Transgenic mouse model of alzheimer disease. Proc Natl Acad Sci U S A 94(4):1550\u20131555","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2032_CR56","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nm790","volume":"8","author":"J McLaurin","year":"2002","unstructured":"McLaurin J et al (2002) Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4\u201310 and inhibit cytotoxicity and fibrillogenesis. Nat Med 8(11):1263\u20131269","journal-title":"Nat Med"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02032-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02032-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02032-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T08:03:33Z","timestamp":1749801813000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02032-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2032"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02032-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the supplementary figures are not able viewable and has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments this study were performed in accordance with institutional animal care and use guidelines, and were approved by the Institutional Animal Care and Use Committees (IACUC) at the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (approved case ID: SIAT-IACUC-20220801-NS-NJBZX-HW-A2091-01). Human specimens were obtained from the Massachusetts ADRC Neuropathology Core, Massachusetts General Hospital and used in accordance with the Partners Institutional Review Board (Protocol: Walsh BWH 2011).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DMW is a former employee of and hold stock in Biogen, he is also a consultant for Acumen, Apellis, BrainQr, Convergen and the Dementia Discovery Fund. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}